Evidence map›Paper›PMID 29284425›Full record

ArticleBMC medical imaging2017

MRI texture analysis in differentiating luminal A and luminal B breast cancer molecular subtypes - a feasibility study.

Kirsi Holli-Helenius, Annukka Salminen, Irina Rinta-Kiikka, Ilkka Koskivuo, Nina Brück, Pia Boström, Riitta Parkkola

Open access · goldAbstract read
In one paragraph

Article in BMC medical imaging, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The impact of radiogenomics on breast cancer.American journal of cancer research · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Kirsi Holli-HeleniusDepartment of Medical Physics, Medical Imaging Centre and Hospital Pharmacy, Pirkanmaa Hospital District, Post Box 2000, 33521, Tampere, Finland. kirsi.holli-helenius@pshp.fi.
Annukka SalminenDepartment of Radiology, Tampere University Hospital, Tampere, Finland.
Irina Rinta-KiikkaDepartment of Radiology, Tampere University Hospital, Tampere, Finland.
Ilkka KoskivuoDepartment of Plastic and General Surgery Turku University Hospital, Turku, Finland.
Nina BrückDepartment of Plastic and General Surgery Turku University Hospital, Turku, Finland.
Pia BoströmDepartment of Pathology, University of Turku and Turku University Hospital, Turku, Finland.
Riitta ParkkolaDepartment of Radiology, University of Turku and Turku University Hospital, Turku, Finland.
Tampere University Hospital · FITurku University Hospital · FIUniversity of Turku · FIPirkanmaa Hospital District · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of this study was to use texture analysis (TA) of breast magnetic resonance (MR) images to assist in differentiating estrogen receptor (ER) positive breast cancer molecular subtypes.

methodsTwenty-seven patients with histopathologically proven invasive ductal breast cancer were selected in preliminary study. Tumors were classified into molecular subtypes: luminal A (ER-positive and/or progesterone receptor (PR)-positive, human epidermal growth factor receptor type 2 (HER2) -negative, proliferation marker Ki-67 < 20 and low grade (I)) and luminal B (ER-positive and/or PR-positive, HER2-positive or HER2-negative with high Ki-67 ≥ 20 and higher grade (II or III)). Co-occurrence matrix -based texture features were extracted from each tumor on T1-weighted non fat saturated pre- and postcontrast MR images using TA software MaZda. Texture parameters and tumour volumes were correlated with tumour prognostic factors.

resultsTextural differences were observed mainly in precontrast images. The two most discriminative texture parameters to differentiate luminal A and luminal B subtypes were sum entropy and sum variance (p = 0.003). The AUCs were 0.828 for sum entropy (p = 0.004), and 0.833 for sum variance (p = 0.003), and 0.878 for the model combining texture features sum entropy, sum variance (p = 0.001). In the LOOCV, the AUC for model combining features sum entropy and sum variance was 0.876. Sum entropy and sum variance showed positive correlation with higher Ki-67 index. Luminal B types were larger in volume and moderate correlation between larger tumour volume and higher Ki-67 index was also observed (r = 0.499, p = 0.008).

conclusionsTexture features which measure randomness, heterogeneity or smoothness and homogeneity may either directly or indirectly reflect underlying growth patterns of breast tumours. TA and volumetric analysis may provide a way to evaluate the biologic aggressiveness of breast tumours and provide aid in decisions regarding therapeutic efficacy.

Indexed as

Breast NeoplasmsCarcinoma, Ductal, BreastDiagnosis, DifferentialFeasibility StudiesFemaleHumansMagnetic Resonance ImagingNeoplasm GradingReceptors, EstrogenReceptors, ProgesteroneReceptors, EstrogenReceptors, Progesteronebreast cancerinvasive ductal carcinoma (IDC)magnetic resonance imaging (MRI)prognostic factorstexture analysis (TA)volumetric analysis

Identifiers

PMID29284425
PMCPMC5747252
OpenAlexW2780477573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.